Global Medical Foods Market Size To Worth USD 49.73 Billion By 2033 | CAGR Of 7.24%
The Global Medical Foods Market Size Was Valued at USD 24.73 Billion in 2023 and the Worldwide Medical Foods Market…
19,500€
1,04%
Echtzeit-Aktienkurs MEIJI HOLDINGS CO.LTD
Bid:
Ask:
Nachrichten zur MEIJI HOLDINGS CO.LTD Aktie
Global Flavored Milk Market Size To Worth USD 97.8 Billion By 2033 l CAGR Of 5.96%
The Global Flavored Milk Market Size was Valued at USD 54.8 Billion in 2023 and the Worldwide Flavored Milk Market…
Meiji Seika Pharma meldet positive Ergebnisse der Phase-II-Studie mit ME3183, einem neuartigen hochwirksamen selektiven PDE4-Hemmer, bei Patienten in den USA und Kanada mit mittelschwerer bis schwerer Plaque-Psoriasis
TOKIO (Japan)--(BUSINESS WIRE)--Meiji Seika Pharma Co. Ltd. (Hauptsitz: Tokio, Japan, President und Representative Director: Daikichiro Kobayashi) meldete heute, dass ME3183,…
Household Summer Holiday Budget in Japan Exceeds 70,000 Yen
Tokyo, July 20 (Jiji Press)--Japanese households average budget for this years summer holiday exceeded 70,000 yen for the first time…
Japanese to spend more in summer break for 2nd straight yr: survey
Japanese people plan to increase their spending in the upcoming summer vacation period for the second straight year, with an…
Showcasing Japanese baseball requires saving Meiji Jingu stadium
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...…
Meiji Yasuda to buy group insurance units of U.S.-based Elevance
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...…
Japan FSA to Inspect Meiji Yasuda Life after Scandal of Sales Staff
Tokyo, Feb. 21 (Jiji Press)--Japans Financial Services Agency plans to conduct an on-site inspection of Meiji Yasuda Life Insurance Co.…
Global Hepatitis B Virus (HBV) Vaccine Market Report 2023-2027 Featuring GSK, Merck, Sanofi, Dynavax, LG Chem, VBI Vaccines and Meiji Group Among Others
DUBLIN, Jan. 31, 2023 /PRNewswire/ -- The "Global Hepatitis B Virus (HBV) Vaccine Market: Analysis By End User (Adult &…
Neuartiger Anti-PD-1-Agonist-Antikörper mit immunosuppressiver Wirkung durch gemeinsame Forschung von Meiji Seika Pharma und der Foundation for Biomedical Research and Innovation bei Kobe entdeckt
TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Hauptsitz: Tokio, Japan, President und Representative Director: Daikichiro Kobayashi) und die Foundation for Biomedical…